Woodline Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Woodline Partners’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$683K	Sell	350,000 -350,000	-50%	-$714K	﹤0.01%	953
2026 Q1	$1.72M	Sell	700,000 -350,000	-33%	-$1.17M	0.01%	820
2025 Q4	$4.18M	Hold	1,050,000	–	–	0.02%	663
2025 Q3	$3.97M	Buy	+1,050,000	New	+$3.56M	0.02%	611

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Woodline Partners's NBP Position: Q2 2026 in Review

Woodline Partners reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 50% in Q2 2026, selling an estimated $714K and leaving 350,000 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #953.

Woodline Partners first reported a position in NBP in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.18M in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Woodline Partners held 350,000 shares of NovaBridge Biosciences American Depositary Shares worth $683K as of Q2 2026.
Woodline Partners sold 350,000 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $714K.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Woodline Partners's portfolio in Q2 2026, its #953 holding.
Woodline Partners first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2025 and has held it in 4 quarters since.
Woodline Partners's NovaBridge Biosciences American Depositary Shares position peaked at $4.18M in Q4 2025.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.